Technical Analysis for LIPO - Lipella Pharmaceuticals Inc.

Grade Last Price % Change Price Change
F 2.48 2.70% 0.07
LIPO closed down 3.21 percent on Wednesday, November 20, 2024, on 24 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 2.70%
NR7 Range Contraction 2.70%
Narrow Range Bar Range Contraction 2.70%
Inside Day Range Contraction 2.70%
Wide Bands Range Expansion 2.70%
Oversold Stochastic Weakness 2.70%
Wide Bands Range Expansion -0.60%
Oversold Stochastic Weakness -0.60%
New 52 Week Closing Low Bearish 7.14%
NR7 Range Contraction 7.14%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High about 3 hours ago
10 DMA Resistance about 3 hours ago
2x Volume Pace about 3 hours ago
1.5x Volume Pace about 3 hours ago
3x Volume Pace about 3 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. We believe that this strategy combines many of the cost efficiencies and risk abatements derived from using existing generic drugs with potential patent protections for our proprietary formulations; this strategy allows us to expedite, protect, and monetize our product candidates. Additionally, we maintain a therapeutic focus on diseases with significant, unaddressed morbidity and mortality where no approved drug therapy currently exists, believing that this focus can potentially help reduce the cost, time and risk associated with obtaining marketing approval.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Drug Therapy Generic Drug

Is LIPO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.0
52 Week Low 2.21
Average Volume 193,724
200-Day Moving Average 4.79
50-Day Moving Average 3.23
20-Day Moving Average 2.87
10-Day Moving Average 2.67
Average True Range 0.36
RSI (14) 42.86
ADX 24.35
+DI 13.84
-DI 18.75
Chandelier Exit (Long, 3 ATRs) 2.91
Chandelier Exit (Short, 3 ATRs) 3.30
Upper Bollinger Bands 3.63
Lower Bollinger Band 2.11
Percent B (%b) 0.2
BandWidth 52.79
MACD Line -0.25
MACD Signal Line -0.21
MACD Histogram -0.0435
Fundamentals Value
Market Cap 14.59 Million
Num Shares 6.05 Million
EPS -0.74
Price-to-Earnings (P/E) Ratio -3.26
Price-to-Sales 12.62
Price-to-Book 2.72
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.64
Resistance 3 (R3) 2.64 2.58 2.60
Resistance 2 (R2) 2.58 2.52 2.57 2.59
Resistance 1 (R1) 2.49 2.48 2.46 2.49 2.57
Pivot Point 2.43 2.43 2.41 2.42 2.43
Support 1 (S1) 2.34 2.37 2.31 2.33 2.25
Support 2 (S2) 2.28 2.33 2.27 2.23
Support 3 (S3) 2.19 2.28 2.22
Support 4 (S4) 2.18